Abstract
Sleep-Disordered Breathing (SDB) is characterized by repetitive partial or complete upper airway occlusion during sleep with a high prevalence in the general community, and associated with considerable morbidity and mortality. In the US, approximately 12 million people 30 to 60 years of age have SDB, and 38,000 die each year from cardiovascular disease attributed to SDB. Substantial morbidity and economic costs are associated with untreated SDB, including those related to daytime sleepiness and hypertension, and cardiovascular co-morbidity. There is a crucial need to address the public health impact of this common condition, including the extent to which treatment of SDB may modify the course of other chronic health conditions such as cardiovascular disease. The public health impact of SDB in large part relates to the association of SDB with cardiovascular disease, a leading cause of mortality in the U.S. Several large epidemiological studies have clearly demonstrated that individuals with SDB have a higher prevalence of cardiovascular disease after controlling for potential confounders. These data, along with the high prevalence of SDB, support a high population attributable risk, suggesting that a high percentage of cardiovascular morbidity in the population may be due to SDB.
Keywords: Sleep apnea syndromes, cardiovascular disease, inflammation, oxidative stress, hypertension, arrhythmias, congestive heart failure, stroke
Current Respiratory Medicine Reviews
Title: Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Volume: 3 Issue: 4
Author(s): Reena Mehra
Affiliation:
Keywords: Sleep apnea syndromes, cardiovascular disease, inflammation, oxidative stress, hypertension, arrhythmias, congestive heart failure, stroke
Abstract: Sleep-Disordered Breathing (SDB) is characterized by repetitive partial or complete upper airway occlusion during sleep with a high prevalence in the general community, and associated with considerable morbidity and mortality. In the US, approximately 12 million people 30 to 60 years of age have SDB, and 38,000 die each year from cardiovascular disease attributed to SDB. Substantial morbidity and economic costs are associated with untreated SDB, including those related to daytime sleepiness and hypertension, and cardiovascular co-morbidity. There is a crucial need to address the public health impact of this common condition, including the extent to which treatment of SDB may modify the course of other chronic health conditions such as cardiovascular disease. The public health impact of SDB in large part relates to the association of SDB with cardiovascular disease, a leading cause of mortality in the U.S. Several large epidemiological studies have clearly demonstrated that individuals with SDB have a higher prevalence of cardiovascular disease after controlling for potential confounders. These data, along with the high prevalence of SDB, support a high population attributable risk, suggesting that a high percentage of cardiovascular morbidity in the population may be due to SDB.
Export Options
About this article
Cite this article as:
Mehra Reena, Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359959
DOI https://dx.doi.org/10.2174/157339807782359959 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
Current Medicinal Chemistry Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms
Current Drug Targets Platelet SERT as a Peripheral Biomarker of Serotonergic Neurotransmission in the Central Nervous System
Current Medicinal Chemistry Teenage-Pregnancies - A Biomedical and a Sociocultural Approach to a Current Problem
Current Women`s Health Reviews Subject Index To Volume 2
Current Cardiology Reviews The Mechanisms of Gastric Mucosal Injury: Focus on Microvascular Endothelium as a Key Target
Current Medicinal Chemistry New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
Current Drug Targets TRP Channels: Emerging Links Between Ca2+, Kidney and Hypertension
Current Hypertension Reviews Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases
Current Drug Targets Anticoagulants in Cirrhotic Patients: Controversies and Certainties in PVT Management
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of ROS and RNS in Regulating Life and Death of Blood Monocytes
Current Pharmaceutical Design Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[3,4-b][1,3,4]Thiadiazoles and [1,2,4]Triazolo[3,4-b][1,3,4]Thiadiazines
Letters in Drug Design & Discovery Effect of Standardized Hydroalcoholic Extract of Saffron Stamen on High Blood Pressure and Baroreflex Sensitivity in Anesthetized Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Development in Tissue-Engineered Vascular Grafts
Vascular Disease Prevention (Discontinued) Role of Renin-Angiotensin System in Vascular Endothelial Dysfunction of Pregnancy-Induced Hypertension
Current Hypertension Reviews Nutriproteomics – Linking Proteomics Variation with Personalized Nutrition
Current Pharmacogenomics and Personalized Medicine Recent Clinical Evidence for the Treatment of Osteoarthritis: What we have Learned
Reviews on Recent Clinical Trials In Vitro and In Vivo Assessment of Matrix Type Transdermal Therapeutic System of Labetalol Hydrochloride
Current Drug Delivery Author Index To Volume 2
Current Hypertension Reviews Monitoring Calcific Aortic Valve Disease: The Role of Biomarkers
Current Medicinal Chemistry